nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—AR—type 2 diabetes mellitus	0.328	1	CbGaD
Nilutamide—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0346	0.0723	CbGbCtD
Nilutamide—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0276	0.0578	CbGbCtD
Nilutamide—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.025	0.0523	CbGbCtD
Nilutamide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0247	0.0516	CbGbCtD
Nilutamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0241	0.0504	CbGbCtD
Nilutamide—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0231	0.0483	CbGbCtD
Nilutamide—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0223	0.0466	CbGbCtD
Nilutamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0221	0.0461	CbGbCtD
Nilutamide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.021	0.0439	CbGbCtD
Nilutamide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.021	0.0439	CbGbCtD
Nilutamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0205	0.0429	CbGbCtD
Nilutamide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0194	0.0405	CbGbCtD
Nilutamide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0187	0.0391	CbGbCtD
Nilutamide—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0182	0.038	CbGbCtD
Nilutamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0174	0.0365	CbGbCtD
Nilutamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0174	0.0365	CbGbCtD
Nilutamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0161	0.0337	CbGbCtD
Nilutamide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0155	0.0325	CbGbCtD
Nilutamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0142	0.0297	CbGbCtD
Nilutamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0132	0.0276	CbGbCtD
Nilutamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0127	0.0265	CbGbCtD
Nilutamide—CYP2C8—Losartan—type 2 diabetes mellitus	0.0117	0.0245	CbGbCtD
Nilutamide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0107	0.0225	CbGbCtD
Nilutamide—CYP2C19—Losartan—type 2 diabetes mellitus	0.00982	0.0205	CbGbCtD
Nilutamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00892	0.0187	CbGbCtD
Nilutamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.00816	0.0171	CbGbCtD
Nilutamide—AR—penis—type 2 diabetes mellitus	0.00105	0.282	CbGeAlD
Nilutamide—Flutamide—AR—type 2 diabetes mellitus	0.000976	0.28	CrCbGaD
Nilutamide—Enzalutamide—AR—type 2 diabetes mellitus	0.000892	0.256	CrCbGaD
Nilutamide—Flutamide—CYP1A2—type 2 diabetes mellitus	0.000579	0.166	CrCbGaD
Nilutamide—POR—islet of Langerhans—type 2 diabetes mellitus	0.000395	0.106	CbGeAlD
Nilutamide—Flutamide—CYP3A4—type 2 diabetes mellitus	0.000384	0.11	CrCbGaD
Nilutamide—Enzalutamide—CYP3A4—type 2 diabetes mellitus	0.000351	0.101	CrCbGaD
Nilutamide—POR—nephron tubule—type 2 diabetes mellitus	0.000318	0.0854	CbGeAlD
Nilutamide—Enzalutamide—ALB—type 2 diabetes mellitus	0.000306	0.0877	CrCbGaD
Nilutamide—POR—cortex of kidney—type 2 diabetes mellitus	0.000272	0.0731	CbGeAlD
Nilutamide—POR—adipose tissue—type 2 diabetes mellitus	0.000252	0.0677	CbGeAlD
Nilutamide—POR—liver—type 2 diabetes mellitus	0.000177	0.0475	CbGeAlD
Nilutamide—AR—cardiovascular system—type 2 diabetes mellitus	0.000169	0.0453	CbGeAlD
Nilutamide—AR—kidney—type 2 diabetes mellitus	0.000165	0.0444	CbGeAlD
Nilutamide—AR—cortex of kidney—type 2 diabetes mellitus	0.000161	0.0432	CbGeAlD
Nilutamide—AR—adipose tissue—type 2 diabetes mellitus	0.000149	0.04	CbGeAlD
Nilutamide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000142	0.000979	CcSEcCtD
Nilutamide—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000142	0.000975	CcSEcCtD
Nilutamide—Tension—Irbesartan—type 2 diabetes mellitus	0.000141	0.000973	CcSEcCtD
Nilutamide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000141	0.000972	CcSEcCtD
Nilutamide—Chest pain—Orlistat—type 2 diabetes mellitus	0.000141	0.000971	CcSEcCtD
Nilutamide—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00014	0.000963	CcSEcCtD
Nilutamide—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00014	0.000961	CcSEcCtD
Nilutamide—Discomfort—Orlistat—type 2 diabetes mellitus	0.000139	0.000959	CcSEcCtD
Nilutamide—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000138	0.00095	CcSEcCtD
Nilutamide—Malaise—Metformin—type 2 diabetes mellitus	0.000138	0.000948	CcSEcCtD
Nilutamide—Alopecia—Losartan—type 2 diabetes mellitus	0.000138	0.000948	CcSEcCtD
Nilutamide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000138	0.000947	CcSEcCtD
Nilutamide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000137	0.000944	CcSEcCtD
Nilutamide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000137	0.000943	CcSEcCtD
Nilutamide—Syncope—Metformin—type 2 diabetes mellitus	0.000137	0.000943	CcSEcCtD
Nilutamide—Oedema—Valsartan—type 2 diabetes mellitus	0.000137	0.000942	CcSEcCtD
Nilutamide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000137	0.000941	CcSEcCtD
Nilutamide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000136	0.00094	CcSEcCtD
Nilutamide—Rash—Glipizide—type 2 diabetes mellitus	0.000136	0.000935	CcSEcCtD
Nilutamide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000136	0.000935	CcSEcCtD
Nilutamide—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000136	0.000934	CcSEcCtD
Nilutamide—Oedema—Orlistat—type 2 diabetes mellitus	0.000135	0.000931	CcSEcCtD
Nilutamide—Headache—Glipizide—type 2 diabetes mellitus	0.000135	0.000929	CcSEcCtD
Nilutamide—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000135	0.000927	CcSEcCtD
Nilutamide—Shock—Valsartan—type 2 diabetes mellitus	0.000135	0.000927	CcSEcCtD
Nilutamide—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000134	0.000924	CcSEcCtD
Nilutamide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000134	0.000921	CcSEcCtD
Nilutamide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000134	0.00092	CcSEcCtD
Nilutamide—CYP2C8—kidney—type 2 diabetes mellitus	0.000134	0.0359	CbGeAlD
Nilutamide—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000133	0.000917	CcSEcCtD
Nilutamide—Tension—Losartan—type 2 diabetes mellitus	0.000133	0.000916	CcSEcCtD
Nilutamide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000133	0.000915	CcSEcCtD
Nilutamide—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000133	0.000914	CcSEcCtD
Nilutamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000133	0.000913	CcSEcCtD
Nilutamide—Hypertension—Metformin—type 2 diabetes mellitus	0.000132	0.000907	CcSEcCtD
Nilutamide—Nervousness—Losartan—type 2 diabetes mellitus	0.000132	0.000907	CcSEcCtD
Nilutamide—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000132	0.000906	CcSEcCtD
Nilutamide—Back pain—Losartan—type 2 diabetes mellitus	0.000131	0.000903	CcSEcCtD
Nilutamide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000131	0.000903	CcSEcCtD
Nilutamide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000131	0.000902	CcSEcCtD
Nilutamide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000131	0.0009	CcSEcCtD
Nilutamide—Anorexia—Valsartan—type 2 diabetes mellitus	0.00013	0.000898	CcSEcCtD
Nilutamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00013	0.000896	CcSEcCtD
Nilutamide—Chest pain—Metformin—type 2 diabetes mellitus	0.00013	0.000895	CcSEcCtD
Nilutamide—Malaise—Irbesartan—type 2 diabetes mellitus	0.00013	0.000894	CcSEcCtD
Nilutamide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000129	0.00089	CcSEcCtD
Nilutamide—Syncope—Irbesartan—type 2 diabetes mellitus	0.000129	0.000889	CcSEcCtD
Nilutamide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000888	CcSEcCtD
Nilutamide—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000129	0.000886	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000129	0.000885	CcSEcCtD
Nilutamide—Discomfort—Metformin—type 2 diabetes mellitus	0.000128	0.000884	CcSEcCtD
Nilutamide—Nausea—Glipizide—type 2 diabetes mellitus	0.000128	0.000881	CcSEcCtD
Nilutamide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000128	0.00088	CcSEcCtD
Nilutamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000127	0.000877	CcSEcCtD
Nilutamide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000127	0.000877	CcSEcCtD
Nilutamide—Pain—Gliclazide—type 2 diabetes mellitus	0.000127	0.000877	CcSEcCtD
Nilutamide—Rash—Glimepiride—type 2 diabetes mellitus	0.000127	0.000873	CcSEcCtD
Nilutamide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000127	0.000872	CcSEcCtD
Nilutamide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000127	0.000872	CcSEcCtD
Nilutamide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000126	0.00087	CcSEcCtD
Nilutamide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000126	0.000869	CcSEcCtD
Nilutamide—Headache—Glimepiride—type 2 diabetes mellitus	0.000126	0.000867	CcSEcCtD
Nilutamide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000126	0.000866	CcSEcCtD
Nilutamide—Cough—Irbesartan—type 2 diabetes mellitus	0.000126	0.000865	CcSEcCtD
Nilutamide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000126	0.000865	CcSEcCtD
Nilutamide—Anaemia—Losartan—type 2 diabetes mellitus	0.000125	0.000863	CcSEcCtD
Nilutamide—Oedema—Metformin—type 2 diabetes mellitus	0.000125	0.000858	CcSEcCtD
Nilutamide—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000124	0.000856	CcSEcCtD
Nilutamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000855	CcSEcCtD
Nilutamide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000124	0.000852	CcSEcCtD
Nilutamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000123	0.000846	CcSEcCtD
Nilutamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000123	0.000845	CcSEcCtD
Nilutamide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000123	0.000844	CcSEcCtD
Nilutamide—Shock—Metformin—type 2 diabetes mellitus	0.000123	0.000844	CcSEcCtD
Nilutamide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000122	0.000842	CcSEcCtD
Nilutamide—Malaise—Losartan—type 2 diabetes mellitus	0.000122	0.000842	CcSEcCtD
Nilutamide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000122	0.00084	CcSEcCtD
Nilutamide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000122	0.000838	CcSEcCtD
Nilutamide—Syncope—Losartan—type 2 diabetes mellitus	0.000122	0.000837	CcSEcCtD
Nilutamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000121	0.000836	CcSEcCtD
Nilutamide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000121	0.000836	CcSEcCtD
Nilutamide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000121	0.0326	CbGeAlD
Nilutamide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000121	0.000834	CcSEcCtD
Nilutamide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00012	0.000829	CcSEcCtD
Nilutamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00012	0.000829	CcSEcCtD
Nilutamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000826	CcSEcCtD
Nilutamide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00012	0.000826	CcSEcCtD
Nilutamide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000119	0.000822	CcSEcCtD
Nilutamide—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000119	0.00082	CcSEcCtD
Nilutamide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000119	0.00082	CcSEcCtD
Nilutamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000119	0.000819	CcSEcCtD
Nilutamide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000119	0.000819	CcSEcCtD
Nilutamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000119	0.000819	CcSEcCtD
Nilutamide—Anorexia—Metformin—type 2 diabetes mellitus	0.000119	0.000818	CcSEcCtD
Nilutamide—Cough—Losartan—type 2 diabetes mellitus	0.000118	0.000815	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000118	0.000813	CcSEcCtD
Nilutamide—Alopecia—Ramipril—type 2 diabetes mellitus	0.000118	0.000812	CcSEcCtD
Nilutamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000118	0.00081	CcSEcCtD
Nilutamide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000118	0.00081	CcSEcCtD
Nilutamide—Oedema—Irbesartan—type 2 diabetes mellitus	0.000118	0.000809	CcSEcCtD
Nilutamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000117	0.000809	CcSEcCtD
Nilutamide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000117	0.000808	CcSEcCtD
Nilutamide—Constipation—Valsartan—type 2 diabetes mellitus	0.000117	0.000805	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000117	0.000804	CcSEcCtD
Nilutamide—Shock—Irbesartan—type 2 diabetes mellitus	0.000116	0.000796	CcSEcCtD
Nilutamide—Pain—Orlistat—type 2 diabetes mellitus	0.000116	0.000796	CcSEcCtD
Nilutamide—Chest pain—Losartan—type 2 diabetes mellitus	0.000115	0.000795	CcSEcCtD
Nilutamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000794	CcSEcCtD
Nilutamide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000787	CcSEcCtD
Nilutamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000787	CcSEcCtD
Nilutamide—Tension—Ramipril—type 2 diabetes mellitus	0.000114	0.000785	CcSEcCtD
Nilutamide—Discomfort—Losartan—type 2 diabetes mellitus	0.000114	0.000785	CcSEcCtD
Nilutamide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000114	0.000783	CcSEcCtD
Nilutamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000782	CcSEcCtD
Nilutamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000113	0.000781	CcSEcCtD
Nilutamide—Nervousness—Ramipril—type 2 diabetes mellitus	0.000113	0.000777	CcSEcCtD
Nilutamide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000113	0.000777	CcSEcCtD
Nilutamide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000772	CcSEcCtD
Nilutamide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000112	0.00077	CcSEcCtD
Nilutamide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000112	0.00077	CcSEcCtD
Nilutamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000111	0.000767	CcSEcCtD
Nilutamide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000111	0.000765	CcSEcCtD
Nilutamide—Oedema—Losartan—type 2 diabetes mellitus	0.000111	0.000762	CcSEcCtD
Nilutamide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000111	0.000761	CcSEcCtD
Nilutamide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00011	0.000755	CcSEcCtD
Nilutamide—Shock—Losartan—type 2 diabetes mellitus	0.000109	0.000749	CcSEcCtD
Nilutamide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000108	0.000746	CcSEcCtD
Nilutamide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000108	0.000745	CcSEcCtD
Nilutamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000108	0.000743	CcSEcCtD
Nilutamide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000108	0.000742	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000108	0.000741	CcSEcCtD
Nilutamide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000107	0.000736	CcSEcCtD
Nilutamide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000107	0.000736	CcSEcCtD
Nilutamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000107	0.000736	CcSEcCtD
Nilutamide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000107	0.000736	CcSEcCtD
Nilutamide—Constipation—Metformin—type 2 diabetes mellitus	0.000107	0.000734	CcSEcCtD
Nilutamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000727	CcSEcCtD
Nilutamide—Anorexia—Losartan—type 2 diabetes mellitus	0.000105	0.000726	CcSEcCtD
Nilutamide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000105	0.000726	CcSEcCtD
Nilutamide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000105	0.000725	CcSEcCtD
Nilutamide—Malaise—Ramipril—type 2 diabetes mellitus	0.000105	0.000722	CcSEcCtD
Nilutamide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000105	0.000722	CcSEcCtD
Nilutamide—Rash—Glyburide—type 2 diabetes mellitus	0.000105	0.00072	CcSEcCtD
Nilutamide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000104	0.000719	CcSEcCtD
Nilutamide—AR—liver—type 2 diabetes mellitus	0.000104	0.028	CbGeAlD
Nilutamide—Syncope—Ramipril—type 2 diabetes mellitus	0.000104	0.000718	CcSEcCtD
Nilutamide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000104	0.000716	CcSEcCtD
Nilutamide—Headache—Glyburide—type 2 diabetes mellitus	0.000104	0.000715	CcSEcCtD
Nilutamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000713	CcSEcCtD
Nilutamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000103	0.000707	CcSEcCtD
Nilutamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000102	0.000704	CcSEcCtD
Nilutamide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000102	0.000703	CcSEcCtD
Nilutamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000102	0.000701	CcSEcCtD
Nilutamide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000102	0.000701	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000101	0.000699	CcSEcCtD
Nilutamide—Cough—Ramipril—type 2 diabetes mellitus	0.000101	0.000698	CcSEcCtD
Nilutamide—Pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.000692	CcSEcCtD
Nilutamide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000101	0.000692	CcSEcCtD
Nilutamide—Insomnia—Losartan—type 2 diabetes mellitus	0.0001	0.000689	CcSEcCtD
Nilutamide—Paraesthesia—Losartan—type 2 diabetes mellitus	9.93e-05	0.000684	CcSEcCtD
Nilutamide—Chest pain—Ramipril—type 2 diabetes mellitus	9.89e-05	0.000681	CcSEcCtD
Nilutamide—Dyspnoea—Losartan—type 2 diabetes mellitus	9.86e-05	0.000679	CcSEcCtD
Nilutamide—Nausea—Glyburide—type 2 diabetes mellitus	9.85e-05	0.000678	CcSEcCtD
Nilutamide—Abdominal pain—Metformin—type 2 diabetes mellitus	9.85e-05	0.000678	CcSEcCtD
Nilutamide—Dizziness—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.000678	CcSEcCtD
Nilutamide—Asthenia—Valsartan—type 2 diabetes mellitus	9.81e-05	0.000676	CcSEcCtD
Nilutamide—Discomfort—Ramipril—type 2 diabetes mellitus	9.78e-05	0.000673	CcSEcCtD
Nilutamide—Dyspepsia—Losartan—type 2 diabetes mellitus	9.74e-05	0.000671	CcSEcCtD
Nilutamide—Asthenia—Orlistat—type 2 diabetes mellitus	9.7e-05	0.000668	CcSEcCtD
Nilutamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.69e-05	0.000667	CcSEcCtD
Nilutamide—Pruritus—Valsartan—type 2 diabetes mellitus	9.68e-05	0.000666	CcSEcCtD
Nilutamide—Dry mouth—Ramipril—type 2 diabetes mellitus	9.68e-05	0.000666	CcSEcCtD
Nilutamide—CYP2C19—liver—type 2 diabetes mellitus	9.67e-05	0.026	CbGeAlD
Nilutamide—Decreased appetite—Losartan—type 2 diabetes mellitus	9.62e-05	0.000662	CcSEcCtD
Nilutamide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.000662	CcSEcCtD
Nilutamide—Pruritus—Orlistat—type 2 diabetes mellitus	9.56e-05	0.000658	CcSEcCtD
Nilutamide—Oedema—Ramipril—type 2 diabetes mellitus	9.49e-05	0.000653	CcSEcCtD
Nilutamide—Vomiting—Gliclazide—type 2 diabetes mellitus	9.47e-05	0.000652	CcSEcCtD
Nilutamide—Constipation—Losartan—type 2 diabetes mellitus	9.46e-05	0.000651	CcSEcCtD
Nilutamide—Pain—Losartan—type 2 diabetes mellitus	9.46e-05	0.000651	CcSEcCtD
Nilutamide—Rash—Gliclazide—type 2 diabetes mellitus	9.39e-05	0.000646	CcSEcCtD
Nilutamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.38e-05	0.000646	CcSEcCtD
Nilutamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.36e-05	0.000644	CcSEcCtD
Nilutamide—Shock—Ramipril—type 2 diabetes mellitus	9.33e-05	0.000643	CcSEcCtD
Nilutamide—Headache—Gliclazide—type 2 diabetes mellitus	9.33e-05	0.000642	CcSEcCtD
Nilutamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.29e-05	0.00064	CcSEcCtD
Nilutamide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.29e-05	0.00064	CcSEcCtD
Nilutamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.25e-05	0.000637	CcSEcCtD
Nilutamide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.17e-05	0.000631	CcSEcCtD
Nilutamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.12e-05	0.000628	CcSEcCtD
Nilutamide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.05e-05	0.000623	CcSEcCtD
Nilutamide—Dizziness—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000623	CcSEcCtD
Nilutamide—Anorexia—Ramipril—type 2 diabetes mellitus	9.04e-05	0.000623	CcSEcCtD
Nilutamide—Dizziness—Orlistat—type 2 diabetes mellitus	8.94e-05	0.000615	CcSEcCtD
Nilutamide—Asthenia—Metformin—type 2 diabetes mellitus	8.94e-05	0.000615	CcSEcCtD
Nilutamide—Nausea—Gliclazide—type 2 diabetes mellitus	8.84e-05	0.000609	CcSEcCtD
Nilutamide—Pruritus—Metformin—type 2 diabetes mellitus	8.81e-05	0.000607	CcSEcCtD
Nilutamide—Body temperature increased—Losartan—type 2 diabetes mellitus	8.74e-05	0.000602	CcSEcCtD
Nilutamide—Abdominal pain—Losartan—type 2 diabetes mellitus	8.74e-05	0.000602	CcSEcCtD
Nilutamide—Vomiting—Valsartan—type 2 diabetes mellitus	8.7e-05	0.000599	CcSEcCtD
Nilutamide—Rash—Valsartan—type 2 diabetes mellitus	8.62e-05	0.000594	CcSEcCtD
Nilutamide—Dermatitis—Valsartan—type 2 diabetes mellitus	8.62e-05	0.000593	CcSEcCtD
Nilutamide—Vomiting—Orlistat—type 2 diabetes mellitus	8.59e-05	0.000592	CcSEcCtD
Nilutamide—Insomnia—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000591	CcSEcCtD
Nilutamide—Headache—Valsartan—type 2 diabetes mellitus	8.57e-05	0.00059	CcSEcCtD
Nilutamide—Diarrhoea—Metformin—type 2 diabetes mellitus	8.52e-05	0.000587	CcSEcCtD
Nilutamide—Rash—Orlistat—type 2 diabetes mellitus	8.52e-05	0.000587	CcSEcCtD
Nilutamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.52e-05	0.000587	CcSEcCtD
Nilutamide—Dermatitis—Orlistat—type 2 diabetes mellitus	8.51e-05	0.000586	CcSEcCtD
Nilutamide—Headache—Orlistat—type 2 diabetes mellitus	8.47e-05	0.000583	CcSEcCtD
Nilutamide—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.46e-05	0.000582	CcSEcCtD
Nilutamide—CYP2C8—liver—type 2 diabetes mellitus	8.44e-05	0.0227	CbGeAlD
Nilutamide—Asthenia—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000581	CcSEcCtD
Nilutamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000575	CcSEcCtD
Nilutamide—Pruritus—Irbesartan—type 2 diabetes mellitus	8.32e-05	0.000573	CcSEcCtD
Nilutamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000568	CcSEcCtD
Nilutamide—Dizziness—Metformin—type 2 diabetes mellitus	8.24e-05	0.000567	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.19e-05	0.000564	CcSEcCtD
Nilutamide—Nausea—Valsartan—type 2 diabetes mellitus	8.12e-05	0.000559	CcSEcCtD
Nilutamide—Constipation—Ramipril—type 2 diabetes mellitus	8.11e-05	0.000559	CcSEcCtD
Nilutamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000554	CcSEcCtD
Nilutamide—Nausea—Orlistat—type 2 diabetes mellitus	8.03e-05	0.000553	CcSEcCtD
Nilutamide—Asthenia—Losartan—type 2 diabetes mellitus	7.94e-05	0.000547	CcSEcCtD
Nilutamide—Vomiting—Metformin—type 2 diabetes mellitus	7.92e-05	0.000545	CcSEcCtD
Nilutamide—Rash—Metformin—type 2 diabetes mellitus	7.85e-05	0.000541	CcSEcCtD
Nilutamide—Dermatitis—Metformin—type 2 diabetes mellitus	7.85e-05	0.00054	CcSEcCtD
Nilutamide—Pruritus—Losartan—type 2 diabetes mellitus	7.83e-05	0.000539	CcSEcCtD
Nilutamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000538	CcSEcCtD
Nilutamide—Headache—Metformin—type 2 diabetes mellitus	7.8e-05	0.000537	CcSEcCtD
Nilutamide—Dizziness—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000535	CcSEcCtD
Nilutamide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000534	CcSEcCtD
Nilutamide—Diarrhoea—Losartan—type 2 diabetes mellitus	7.57e-05	0.000521	CcSEcCtD
Nilutamide—CYP2C9—liver—type 2 diabetes mellitus	7.5e-05	0.0201	CbGeAlD
Nilutamide—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.5e-05	0.000516	CcSEcCtD
Nilutamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.5e-05	0.000516	CcSEcCtD
Nilutamide—Vomiting—Irbesartan—type 2 diabetes mellitus	7.47e-05	0.000515	CcSEcCtD
Nilutamide—Rash—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.00051	CcSEcCtD
Nilutamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.4e-05	0.00051	CcSEcCtD
Nilutamide—Nausea—Metformin—type 2 diabetes mellitus	7.4e-05	0.000509	CcSEcCtD
Nilutamide—Headache—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000507	CcSEcCtD
Nilutamide—Dizziness—Losartan—type 2 diabetes mellitus	7.31e-05	0.000504	CcSEcCtD
Nilutamide—Vomiting—Losartan—type 2 diabetes mellitus	7.03e-05	0.000484	CcSEcCtD
Nilutamide—Nausea—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000481	CcSEcCtD
Nilutamide—Rash—Losartan—type 2 diabetes mellitus	6.97e-05	0.00048	CcSEcCtD
Nilutamide—Dermatitis—Losartan—type 2 diabetes mellitus	6.97e-05	0.00048	CcSEcCtD
Nilutamide—Headache—Losartan—type 2 diabetes mellitus	6.93e-05	0.000477	CcSEcCtD
Nilutamide—Asthenia—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000469	CcSEcCtD
Nilutamide—Pruritus—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000462	CcSEcCtD
Nilutamide—Nausea—Losartan—type 2 diabetes mellitus	6.57e-05	0.000452	CcSEcCtD
Nilutamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000447	CcSEcCtD
Nilutamide—Dizziness—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000432	CcSEcCtD
Nilutamide—Vomiting—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000415	CcSEcCtD
Nilutamide—Rash—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000412	CcSEcCtD
Nilutamide—Dermatitis—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000411	CcSEcCtD
Nilutamide—Headache—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000409	CcSEcCtD
Nilutamide—Nausea—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000388	CcSEcCtD
Nilutamide—CYP2C19—Metabolism—CYTB—type 2 diabetes mellitus	1.38e-05	0.000332	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.38e-05	0.000332	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCC8—type 2 diabetes mellitus	1.37e-05	0.000332	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CBS—type 2 diabetes mellitus	1.37e-05	0.000332	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	1.37e-05	0.000331	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	1.37e-05	0.000331	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	1.37e-05	0.000331	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	1.37e-05	0.000331	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.37e-05	0.000331	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR3C1—type 2 diabetes mellitus	1.36e-05	0.00033	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.36e-05	0.000328	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SRD5A1—type 2 diabetes mellitus	1.34e-05	0.000324	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	1.33e-05	0.000321	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—COX2—type 2 diabetes mellitus	1.32e-05	0.000319	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC5A2—type 2 diabetes mellitus	1.32e-05	0.000319	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NCOA6—type 2 diabetes mellitus	1.3e-05	0.000314	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.3e-05	0.000314	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HSD17B3—type 2 diabetes mellitus	1.28e-05	0.000309	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ACACA—type 2 diabetes mellitus	1.28e-05	0.000309	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—STAR—type 2 diabetes mellitus	1.28e-05	0.000309	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.28e-05	0.000309	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARA—type 2 diabetes mellitus	1.28e-05	0.000309	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—UCP2—type 2 diabetes mellitus	1.28e-05	0.000308	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—UCP3—type 2 diabetes mellitus	1.28e-05	0.000308	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HSD11B1—type 2 diabetes mellitus	1.28e-05	0.000308	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	1.25e-05	0.000303	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	1.25e-05	0.000303	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.24e-05	0.000299	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCC8—type 2 diabetes mellitus	1.23e-05	0.000296	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CBS—type 2 diabetes mellitus	1.23e-05	0.000296	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	1.22e-05	0.000295	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PCK1—type 2 diabetes mellitus	1.2e-05	0.00029	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.18e-05	0.000286	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	1.18e-05	0.000285	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	1.18e-05	0.000285	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.17e-05	0.000282	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.17e-05	0.000282	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.17e-05	0.000282	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	1.16e-05	0.00028	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.16e-05	0.00028	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.15e-05	0.000279	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	1.14e-05	0.000275	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	1.14e-05	0.000275	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	1.14e-05	0.000275	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HK1—type 2 diabetes mellitus	1.12e-05	0.000272	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.12e-05	0.000271	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.12e-05	0.00027	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.12e-05	0.00027	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.1e-05	0.000267	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LPA—type 2 diabetes mellitus	1.09e-05	0.000262	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GCKR—type 2 diabetes mellitus	1.09e-05	0.000262	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HSD3B2—type 2 diabetes mellitus	1.09e-05	0.000262	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—KCNJ11—type 2 diabetes mellitus	1.09e-05	0.000262	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.08e-05	0.00026	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.08e-05	0.00026	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	1.07e-05	0.000259	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.06e-05	0.000255	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.06e-05	0.000255	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARG—type 2 diabetes mellitus	1.06e-05	0.000255	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.05e-05	0.000255	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.04e-05	0.000252	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	1.04e-05	0.000251	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.04e-05	0.000251	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.04e-05	0.000251	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.04e-05	0.000251	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.03e-05	0.000249	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.01e-05	0.000244	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.01e-05	0.000243	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	1e-05	0.000242	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1e-05	0.000242	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.91e-06	0.000239	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.79e-06	0.000237	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	9.77e-06	0.000236	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	9.69e-06	0.000234	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	9.69e-06	0.000234	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	9.69e-06	0.000234	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	9.69e-06	0.000234	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	9.68e-06	0.000234	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.62e-06	0.000232	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	9.52e-06	0.00023	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.38e-06	0.000227	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.32e-06	0.000225	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	9.29e-06	0.000224	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	9.15e-06	0.000221	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.14e-06	0.000221	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	9.03e-06	0.000218	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.02e-06	0.000218	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	8.85e-06	0.000214	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	8.85e-06	0.000214	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.84e-06	0.000214	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	8.83e-06	0.000213	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	8.83e-06	0.000213	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	8.83e-06	0.000213	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	8.83e-06	0.000213	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.74e-06	0.000211	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	8.68e-06	0.00021	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	8.64e-06	0.000209	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.63e-06	0.000208	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	8.62e-06	0.000208	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	8.62e-06	0.000208	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	8.62e-06	0.000208	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	8.57e-06	0.000207	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.5e-06	0.000205	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	8.47e-06	0.000205	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	8.42e-06	0.000203	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	8.32e-06	0.000201	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.23e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	8.06e-06	0.000195	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.06e-06	0.000195	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.97e-06	0.000193	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	7.9e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	7.9e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	7.87e-06	0.00019	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.76e-06	0.000187	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	7.75e-06	0.000187	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	7.73e-06	0.000187	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	7.73e-06	0.000187	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	7.73e-06	0.000187	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.7e-06	0.000186	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	7.7e-06	0.000186	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	7.7e-06	0.000186	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	7.7e-06	0.000186	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	7.65e-06	0.000185	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	7.59e-06	0.000183	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	7.52e-06	0.000182	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	7.51e-06	0.000182	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	7.43e-06	0.000179	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.42e-06	0.000179	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	7.36e-06	0.000178	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	7.35e-06	0.000178	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	7.2e-06	0.000174	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	7.2e-06	0.000174	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	7.07e-06	0.000171	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	7.06e-06	0.000171	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.02e-06	0.00017	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	7.02e-06	0.00017	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	7.02e-06	0.00017	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	7.02e-06	0.00017	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	7e-06	0.000169	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	7e-06	0.000169	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.98e-06	0.000169	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.92e-06	0.000167	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	6.9e-06	0.000167	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	6.9e-06	0.000167	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	6.9e-06	0.000167	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	6.85e-06	0.000166	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	6.82e-06	0.000165	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.79e-06	0.000164	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	6.78e-06	0.000164	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.77e-06	0.000164	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	6.72e-06	0.000162	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	6.71e-06	0.000162	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	6.71e-06	0.000162	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.62e-06	0.00016	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	6.57e-06	0.000159	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	6.31e-06	0.000153	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.31e-06	0.000153	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.3e-06	0.000152	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.3e-06	0.000152	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.3e-06	0.000152	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	6.24e-06	0.000151	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	6.24e-06	0.000151	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	6.18e-06	0.000149	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	6.12e-06	0.000148	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	6.09e-06	0.000147	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.06e-06	0.000146	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.04e-06	0.000146	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.99e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	5.99e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	5.99e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	5.78e-06	0.00014	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.78e-06	0.00014	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.76e-06	0.000139	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	5.75e-06	0.000139	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.69e-06	0.000138	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.69e-06	0.000138	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	5.68e-06	0.000137	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.55e-06	0.000134	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.52e-06	0.000133	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	5.51e-06	0.000133	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.46e-06	0.000132	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.46e-06	0.000132	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	5.36e-06	0.00013	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	5.26e-06	0.000127	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	5.16e-06	0.000125	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.16e-06	0.000125	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	5.15e-06	0.000124	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	5.14e-06	0.000124	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	5.13e-06	0.000124	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	5.07e-06	0.000122	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	5e-06	0.000121	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.94e-06	0.000119	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.92e-06	0.000119	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.79e-06	0.000116	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	4.74e-06	0.000114	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.7e-06	0.000114	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.7e-06	0.000114	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.7e-06	0.000114	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.68e-06	0.000113	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	4.65e-06	0.000112	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.62e-06	0.000112	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.6e-06	0.000111	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.58e-06	0.000111	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	4.5e-06	0.000109	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.49e-06	0.000108	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	4.46e-06	0.000108	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	4.43e-06	0.000107	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	4.41e-06	0.000107	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	4.41e-06	0.000106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.36e-06	0.000105	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	4.36e-06	0.000105	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.28e-06	0.000103	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	4.23e-06	0.000102	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.19e-06	0.000101	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.18e-06	0.000101	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—type 2 diabetes mellitus	4.18e-06	0.000101	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	4.15e-06	0.0001	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.07e-06	9.83e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.02e-06	9.71e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	4.02e-06	9.71e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.95e-06	9.55e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.94e-06	9.51e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.89e-06	9.4e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.86e-06	9.32e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.84e-06	9.28e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.78e-06	9.14e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.77e-06	9.11e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.66e-06	8.85e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.6e-06	8.71e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.59e-06	8.67e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.55e-06	8.58e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	3.45e-06	8.35e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.43e-06	8.29e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.36e-06	8.13e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	3.3e-06	7.99e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	3.3e-06	7.99e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.13e-06	7.56e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.08e-06	7.45e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.07e-06	7.41e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	3.02e-06	7.3e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.95e-06	7.13e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.95e-06	7.13e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.81e-06	6.79e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.7e-06	6.52e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.69e-06	6.5e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.69e-06	6.5e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.46e-06	5.94e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.52e-06	3.67e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.36e-06	3.28e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	2.99e-05	CbGpPWpGaD
